RTL1000 is a new agent that has not been previously tested in humans. It is thought that RTL may specifically control the abnormal immune response or attack against the insulation on the nerves that occurs in multiple sclerosis. It is currently in clinical trials.
Stopped using RTL 1000
|This item is relevant to you: Less than 1 month||1||